Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urine IP-10 Guided Treatment to Reduce Lupus Nephritis Flares
TCTR20190517004Phase 4Terminated
- Sponsor
- National Science and Technology Development Agency
- Start
- Jul 2019
- Countries
- 1
01
Overview
Phase 4 trial in lupus nephritis (LN) and systemic lupus erythematosus (SLE), sponsored by National Science and Technology Development Agency. Started Jul 2019; status: terminated.
02
Conditions
lupus nephritis (LN)systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on TCTR20190517004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190517004.